William PayChief Investment & Strategy Advisor to the Chairman at HK WinHealth Pharma GroupSpeaker
Profile
William Pay is the Chief Investment & Strategy Advisor to the Chairman of HK WinHealth Pharma Group, where he advises on global investment strategy, cross-border partnerships, and long-term innovation initiatives. He also serves as a Venture Partner/Advisor with Pappas Capital, supporting early-stage and growth-stage healthcare companies in advancing transformative technologies and expanding international market access. With extensive experience across healthcare, finance, and international business development, William plays a central role in shaping strategic direction and fostering collaborative growth models across Asia, Europe, and the United States. He has worked for multinational pharmaceutical companies including but not limited to IQVIA, Pfizer, JNJ, Takeda, Bayer across three continents, advised emerging biotech firms, and investment institutions on portfolio strategy, market entry, and partnership development. William is a frequent speaker on healthcare innovation, investment trends, and the future of cross-border collaboration.
Agenda Sessions
Master Forum: Partnering with China
, 1:30pmView Session

